August 14, 2015 Nadia RupniakCoLucid Pharmaceuticals, Inc. • November 10th, 2015 • Pharmaceutical preparations
Pursuant to our recent discussions, I would like to outline your current terms of employment with CoLucid Pharmaceuticals, Inc. (“CoLucid” or the “Company”). These terms supersede and replace those set forth in your previous employment letter dated March 14, 2006. The Confidentiality, Inventions and Non-Competition Agreement, dated February 20, 2006, between the Company and you will remain in full force and effect.
September 16, 2015 Ms. Bernice KucaCoLucid Pharmaceuticals, Inc. • November 10th, 2015 • Pharmaceutical preparations
Pursuant to our recent discussions, I would like to outline your current terms of employment with CoLucid Pharmaceuticals, Inc. (“CoLucid” or the “Company”). These terms supersede and replace those set forth in your previous employment letter dated September 17, 2014. The Confidentiality, Inventions and Non-Competition Agreement, dated October 15, 2014, between the Company and you will remain in full force and effect.
AMENDED AND RESTATED CONSULTING AGREEMENTConsulting Agreement • November 10th, 2015 • CoLucid Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
This Amended and Restated Consulting Agreement (this “Agreement”) is entered into as of September 16, 2015, between CoLucid Pharmaceuticals, Inc., a corporation organized under the laws of Delaware (the “Company”), and LLH Associates, LLC, a limited liability company organized under the laws of New Jersey (the “Consulting Firm”). The Consulting Firm has been providing consulting services to the Company pursuant to the Consulting Agreement, dated September 1, 2008, between the parties, as amended (the “Original Agreement”). The Company and the Consulting Firm desire to amend and restate the Original Agreement in its entirety, as set forth herein. Concurrently, the parties are entering into a Confidentiality, Invention Assignment and Non-Competition Agreement (the “Confidentiality Agreement”), which will supersede and replace the Confidentiality Agreement, dated as of July 16, 2008, among them.
